3863 results for «475»
3863 results
Role of PCI in the contemporary management of patients with angina and coronary disease
17 May 2024 – From EuroPCR 2024
This session aims to generate awareness about the distinct phenotypes of coronary artery disease (focal, diffuse, serial) that can be identified through contemporary physiological tools, and the implications of these phenotypes on achieving successful functional PCI results. Participants will also discuss the considerations around using PCI...
Personalised Vascular Care Award ceremony
16 May 2024 – From EuroPCR 2024
This session is the Personalised Vascular Care Award ceremony, sponsored by Abbott. The objectives and details of this session are not provided, as it is likely an event to recognize and celebrate achievements in the field of personalized vascular care.
Complication occurring during PCI of calcified coronary lesions
17 May 2024 – From EuroPCR 2024
Join this in-depth session on the complications encountered during PCI of calcified coronary lesions, featuring real-world challenges like no flow with coronary dissection, stuck wires, and non-dilatable lesions. From the "Kokeshi phenomenon" to IVL-induced RCA dissection, this session highlights key lessons and red flags, emphasizing the...
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
Management of PCI complications - Part 2
17 May 2024 – From EuroPCR 2024
This session focuses on the management of various PCI complications, including iatrogenic dissection after diagnostic coronary angiography, sinus node artery occlusion, a stuck 6F guide in the axillary artery, and the retrieval of a broken balloon. The session features a series of case presentations and discussions,...
Calcified lesions: one big challenge; several good options
17 May 2024 – From EuroPCR 2024
This session delves into the management of calcified coronary lesions, presenting various techniques and tools to address this common challenge. It covers topics such as the use of drug-coated balloons, rotational atherectomy, intravascular lithotripsy, and high-pressure non-compliant balloons. The session also includes a meta-analysis on the...
TAVR in challenging anatomies
17 May 2024 – From EuroPCR 2024
This session focuses on navigating TAVR procedures in complex anatomical scenarios. It covers topics such as optimizing the position of a TAVR valve in a stentless bioprosthesis, managing an unexpected deep position of a TAVR implant, dealing with a completely radiolucent failing surgical bioprosthetic valve, and...
ACS: how to approach special clinical scenarios
17 May 2024 – From EuroPCR 2024
This session focuses on the management of acute coronary syndrome (ACS) in special clinical scenarios. It covers topics such as treating ACS with multivessel disease, managing an ACS and unstable patient, and addressing subacute myocardial infarction. The session features case presentations and discussions, providing insights and...
Thrombus management in a STEMI patient with high clot burden
17 May 2024 – From EuroPCR 2024
Discover the optimal timing for thrombus extraction and explore effective strategies for managing large thrombi. Learn about the latest tools and techniques, as well as the role of pharmacotherapy in supporting successful thrombus removal.
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
Transcatheter solutions for combined valve disease
17 May 2024 – From EuroPCR 2024
This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...
Acute coronary syndromes: keep an eye open for unusual presentations
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions highlighting unusual presentations of acute coronary syndromes. Cases cover topics such as a "ring" completing the "crown", recurrent vasospastic angina culminating in STEMI, myocardial infarction of unusual cause, and primary PCI in dextrocardia. Discussions emphasize the importance...
Update on coronary physiology in 2024
17 May 2024 – From EuroPCR 2024
This session provides an update on the available options for invasive coronary physiology in 2024. It reviews the latest evidence supporting the clinical adoption of invasive physiology indexes and shares practical tips and tricks for their application. Topics covered include CT-based physiology, pressure wire-based physiology, angiography-based...
Optimizing case selection and procedure guidance in transcatheter mitral valve interventions
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...
Recorded case demonstration in TAVI and Mitral
17 Feb 2024 – From PCR Tokyo Valves 2024
This session of record case demonstrations aims to better understand daily clinical practice in TAVI and MitraClip, as well as helping to resolve daily clinical questions in structural heart disease interventions. [In Japanese]
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
Valve-in-Valve
17 Feb 2024 – From PCR Tokyo Valves 2024
Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!
Mitral and tricuspid intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!
Rapid-fire - TAVI concomitant with CAD
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!
The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.